Patents by Inventor Susann Schweiger

Susann Schweiger has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ENHANCEMENT OF PROTEIN PRODUCTION IN EUKARYOTIC CELLS
    Publication number: 20120208233
    Abstract: An embodiment relates to the increased expression of polypeptides in eukaryotic cells. A method for increased production is described using an expression vector comprising a polynucleotide encoding a desired polypeptide and a G quartet like motif sequence.
    Type: Application
    Filed: August 4, 2008
    Publication date: August 16, 2012
    Inventors: Susann Schweiger, Beatriz Aranda-Orgillés, Rainer Schneider, Stefan Roepcke, Sven Krause
  • Treatment of Alzheimer's Disease
    Publication number: 20120184624
    Abstract: The present invention relates to a method of treating and/or preventing Alzheimer's disease and/or other tauopathies.
    Type: Application
    Filed: December 16, 2011
    Publication date: July 19, 2012
    Inventors: Susann Schweiger, Rainer Schneider, Hartmut Glossmann
  • Means for use in treating diseases correlated with or caused by non-physiological levels of microtubule-associated PP2Ac
    Patent number: 8202696
    Abstract: The present invention relates to a method of preventing or treating a disease correlated with or caused by non-physiologically increased intracellular levels of the catalytic subunit of microtubule-associated protein phosphatase 2A (PP2Ac) comprising administering to a subject affected by said disease or in danger of developing said disease a pharmaceutically effective amount of a protein selected from the group of MID1 or MID2 or a nucleic acid encoding said protein.
    Type: Grant
    Filed: May 15, 2003
    Date of Patent: June 19, 2012
    Assignee: Max-Planck-Gessellschaft zur Forderung der Wissenschaften E.V.
    Inventors: Susann Schweiger, Hans-Hilger Ropers, Jennifer Winter, Sybille Krauss, Vanessa Suckow, Rainer Schneider, Alexander Trockenbacher, John Foerster
  • Means for use in treating diseases correlated with or caused by non-physiological levels of microtubule-associated pp2ac
    Publication number: 20070134654
    Abstract: The present invention relates to a method of preventing or treating a disease correlated with or caused by non-physiologically increased intracellular levels of the catalytic subunit of microtubule-associated protein phosphatase 2A (PP2Ac) comprising administering to a subject affected by said disease or in danger of developing said disease a pharmaceutically effective amount of a protein selected from the group of MID1 or MID2 or a nucleic acid encoding said protein.
    Type: Application
    Filed: May 15, 2003
    Publication date: June 14, 2007
    Applicant: Max-Planck-Gesellschaft zur Forderung der Wissenschaften e.V.
    Inventors: Susann Schweiger, Hans-Hilger Ropers, Jennifer Winter, Sybille Krauss, Vanessa Suckow, Rainer Schneider, Alexander Trockenbacher, Lars Klimaschewski, John Foerster, Sebastian Haesler